Progression From Paroxysmal to Sustained Atrial Fibrillation Is Associated With Increased Adverse Events

Author:

Ogawa Hisashi1,An Yoshimori1,Ikeda Syuhei1,Aono Yuya1,Doi Kosuke1,Ishii Mitsuru1,Iguchi Moritake1,Masunaga Nobutoyo1,Esato Masahiro2,Tsuji Hikari3,Wada Hiromichi4,Hasegawa Koji4,Abe Mitsuru1,Lip Gregory Y.H.56,Akao Masaharu1,

Affiliation:

1. From the Department of Cardiology (H.O., Y. An, S.I., Y. Aono, K.D., M. Ishii, M. Iguchi, N.M., M. Abe, M. Akao)

2. Department of Arrhythmia, Ijinkai Takeda General Hospital, Kyoto, Japan (M.E.)

3. Tsuji Clinic, Kyoto, Japan (H.T.)

4. Division of Translational Research (H.W., K.H.), National Hospital Organization Kyoto Medical Center, Japan

5. Institute of Cardiovascular Sciences, University of Birmingham, United Kingdom (G.Y.H.L.)

6. Department of Clinical Medicine, Aalborg Thrombosis Research Unit, Aalborg University, Denmark (G.Y.H.L.).

Abstract

Background and Purpose— Atrial fibrillation (AF) is a common arrhythmic disorder among the elderly and sometimes progresses from paroxysmal to sustained (persistent or permanent) types. Clinical outcomes of patients with progression of AF were unknown. This study assessed the characteristics of patients with AF progression and the impact of AF progression on various clinical events. Methods— The Fushimi AF Registry is a community-based prospective survey of the patients with AF in Fushimi-ku, Kyoto. Analyses were performed on 4045 patients, which included 1974 paroxysmal AF (PAF; 48.8%) and 2071 sustained (persistent or permanent) AF (SAF; 51.2%) at baseline. Results— During the median follow-up period of 1105 days, progression of AF occurred in 252 patients with PAF (4.22 per 100 person-years). Multivariate Cox regression analysis demonstrated that progression of AF was significantly associated with an increased risk of ischemic stroke or systemic embolism (adjusted hazard ratio [HR], 4.10; 95% CI, 1.95–8.24; P <0.001 [versus PAF without progression]; adjusted HR, 2.20; 95% CI, 1.11–4.00; P =0.025 [versus SAF]) during progression period from paroxysmal to sustained forms. The risk after the progression was equivalent to SAF (adjusted HR, 1.54; 95% CI, 0.78–2.75; P =0.201 [versus SAF]). AF progression was significantly associated with a higher risk of hospitalization for heart failure (adjusted HR, 2.70; 95% CI, 1.55–4.52; P <0.001 [versus PAF without progression]; adjusted HR, 1.81; 95% CI, 1.08–2.88; P =0.026 [versus SAF]). Conclusions— Progression of AF was associated with increased risk of clinical adverse events during arrhythmia progression period from PAF to SAF among Japanese patients with AF. The risk of adverse events was transiently elevated during progression period from PAF to SAF and declined to the level equivalent to SAF after the progression. Clinical Trial Registration— URL: http://www.umin.ac.jp/ctr/ . Unique identifier: UMIN000005834.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialized Nursing,Cardiology and Cardiovascular Medicine,Neurology (clinical)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3